The Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine (UMSOM) has been awarded a five-year contract by the National Institute of Allergy and Infectious Diseases (NIAID) at NIH to establish a new Genomic Sequencing Center for Infectious Disease (GSCID).
The Genomic Sequencing Center for Infectious Disease provides researchers with rapid and cost-efficient production of high-quality genome sequences of NIAID Category A-C priority pathogens, related organisms, clinical isolates, closely related species, and invertebrate vectors of infectious diseases and microorganisms responsible for emerging and re-emerging infectious diseases. The GSCID addresses the need for sequencing microorganisms and invertebrate vectors of disease that are considered agents of bioterrorism and/or high priority pathogens that could be public health concerns. Both data and new analytical tools generated by the GSCID will be shared publicly to advance research in pathogenicity, drug resistance, disease transmission and vaccine development.
The Institute for Genome Sciences was selected to participate in this contract because of our expertise in genome sequencing, annotation and analysis. Dr. Claire Fraser, Director of IGS, serves as Principal Investigator for the GSCID. Dr. Lisa Sadzewicz, Administrative Director for the Genomics Resource Center and Project Manager for GSCID, and Luke Tallon, Scientific Director of the Genomics Resource Center at IGS, are leading the sequencing, assembly, and genome finishing efforts. Dr. Owen White, Director of Bioinformatics at the School of Medicine, and Anup Mahurkar, Director of Software Engineering and IT, are leading the annotation and analysis of genome sequences.
In addition to IGS, NIAID has funded two other centers, one at the J. Craig Venter Institute (JCVI) and one at The Broad Institute.